A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-responders.
Zhang G, Jurinovic V, Bartels S, Christgen M, Christgen H, Kandt LD, Mishieva L, Ni H, Raap M, Klein J, Katzke AL, Hofmann W, Steinemann D, Kates RE, Gluz O, Graeser M, Kuemmel S, Nitz U, Plass C, Lehmann U, Zu Eulenburg C, Mansmann U, Gerhauser C, Harbeck N, Kreipe HH.
Zhang G, et al. Among authors: mansmann u.
J Clin Invest. 2025 Jul 24:e177813. doi: 10.1172/JCI177813. Online ahead of print.
J Clin Invest. 2025.
PMID: 40705465
Free article.